Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Synaptec Limited has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 3 distinct examiners, but all are concentrated within 1 distinct art unit. This indicates that while different individuals are reviewing the applications, they are all operating under the same departmental guidelines. Cwern, Jonathan is the busiest examiner for the portfolio, currently managing 1 pending office action.
Because each of the distinct examiners is responsible for a pending office action, the workload is spread across the group. The concentration in the 1 distinct art unit suggests a specific technological scope for the company's current active filings. Practitioners must address the 3 pending office actions by considering the unified standards of the art unit while adapting to the preferences of the examiners. This structure allows for a centralized prosecution strategy within the Medical Devices & Mechanical Engineering sector. The 1 pending office action under Cwern, Jonathan is part of this unified effort.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CWERN, JONATHAN | 1 | 50.9% | +33.3% |
| NGUYEN, HIEN NGOC | 1 | 52.6% | +40.6% |
| MCDONALD, JAMES F | 1 | 59.1% | +42.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18646463 | Systems And Methods For Shockwave Mediated Delivery Of Microvesicles And Stem Cells | CWERN, JONATHAN | — |
| 16706250 | SYSTEMS AND METHODS FOR TARGETED BRAIN STIMULATION | MCDONALD, JAMES F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18510984 | Systems and Methods For Delivering Exosomes Through the Blood-Brain Barrier | NGUYEN, HIEN NGOC | 28d overdue |
| 18646463 | Systems And Methods For Shockwave Mediated Delivery Of Microvesicles And Stem Cells | CWERN, JONATHAN | — |
| 16706250 | SYSTEMS AND METHODS FOR TARGETED BRAIN STIMULATION | MCDONALD, JAMES F | — |
| Art Unit | Apps |
|---|---|
| 3797 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18646463 | Systems And Methods For Shockwave Mediated Delivery Of Microvesicles And Stem Cells | CWERN, JONATHAN | — | §102§103 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18510984 | Systems and Methods For Delivering Exosomes Through the Blood-Brain Barrier | NGUYEN, HIEN NGOC | 3797 | §103 | Final Rejection | 28d overdue | Pending | Nov 16, 2023 |
| 16706250 | SYSTEMS AND METHODS FOR TARGETED BRAIN STIMULATION | MCDONALD, JAMES F | 3797 | §102§103§112 | Final Rejection | — | Pending | Dec 06, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial